Comparing Boniva vs Risedronate
Boniva (ibandronate) | Risedronate |
|
---|
Boniva (ibandronate) | Risedronate |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Boniva helps to increase bone mineral density and is given as a tablet once every month or by injection once every three months. Common side effects include gastrointestinal disturbances and back... View more |
Prescription only
Risedronate helps to reduce the risk of fracture in people with osteoporosis and some other bone conditions. Dosage instructions, including remaining upright for at least 30 minutes and taking with a... View more |
Related suggestions Osteoporosis
Prevention of Osteoporosis
Popular comparisons
|
|||||||
More about Boniva (ibandronate) | More about Risedronate | ||||||||
Ratings & Reviews | |||||||||
Boniva has an average rating of 3.2 out of 10 from a total of 99 ratings on Drugs.com. 17% of reviewers reported a positive effect, while 72% reported a negative effect. |
Risedronate has an average rating of 2.7 out of 10 from a total of 79 ratings on Drugs.com. 15% of reviewers reported a positive effect, while 80% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Boniva side effects |
View all Risedronate side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic approved |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Risedronate prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
Actonel, Atelvia | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
N/A |
561 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 178 drugs are known to interact with Boniva:
|
A total of 112 drugs are known to interact with Risedronate:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
May 16, 2003 |
March 27, 1998 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Atelvia
Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side ...
Evista
Evista is used to treat and prevent osteoporosis in postmenopausal women. Learn about side effects ...
Risedronate
Risedronate is used for osteoporosis, paget's disease, prevention of osteoporosis
Zoledronic acid
Zoledronic acid is used for hypercalcemia of malignancy, osteolytic bone lesions of multiple ...
Raloxifene
Raloxifene is used for breast cancer, prevention, osteoporosis, prevention of osteoporosis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.